Showing 2281-2290 of 2731 results for "".
- RelabotulinumtoxinA Update from Galdermahttps://modernaesthetics.com/news/relabotulinumtoxina-update-from-galderma/2473504/The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Galderma related to its pending Biologics License Application (BLA) for RelabotulinumtoxinA for the treatment of moderate-to-severe glabellar lines associated with corrugator and/or procerus muscle activity
- Galderma Gives Back: New “Facing Breast Cancer Together" Campaign Supports the National Breast Cancer Foundationhttps://modernaesthetics.com/news/galderma-gives-back-new-facing-breast-cancer-together-campaign-supports-the-national-breast-cancer-foundation/2473503/Galderma is launching a new campaign to provide education and support for breast cancer awareness as part of its nine-year partnership with National Breast Cancer Foundation (NBCF), Inc. The survival rate of breast cancer patients has significantly increased due to early diagnosis
- New In My Practice: The Viality Fat Transfer System by Sientra with Dr. David Shaferhttps://modernaesthetics.com/news/new-in-my-practice-the-viality-fat-transfer-system-by-sientra-with-david-shafer-md/2473501/AestheticsWire recently sat down with New York City plastic surgeon David Shafer, MD to discuss how the use of the Viality Fat Transfer System by Sientra has improved his fat transfer procedures. AestheticsWire: What is the Viality Fat Transfer System by Sientra?<
- Will Platysma Prominence Be the Next Nod for BOTOX Cosmetic?https://modernaesthetics.com/news/will-platysma-prominence-be-the-next-nod-for-botox-cosmetic/2473497/Allergan Aesthetics’ BOTOX Cosmetic met all primary and secondary endpoints for the treatment of moderate to severe platysma prominence associated with platysma muscle activity, according to topline results from the second of three Phase 3 studies. The multicenter, randomized
- FDA Grants 510(k) Clearance to Venus the Versa Pro Systemhttps://modernaesthetics.com/news/fda-grants-510k-clearance-to-venus-the-versa-pro-system/2473495/The U.S. Food and Drug Administration has granted marketing clearance to Venus Concept Inc.’s Venus Versa Pro System. Venus Versa is customizable and upgradable and supports 10 optional applicators which utilize Venus Concept’s (MP)2, IPL and NanoFractional RF tec
- ISAPS 2022 Data: Liposuction Remains the Most Popular Plastic Surgery Procedure in the Worldhttps://modernaesthetics.com/news/isaps-2022-data-liposuction-remains-the-most-popular-plastic-surgery-procedure-in-the-world/2473494/Liposuction is continuing its reign as the most popular surgical procedure across the globe, according to the newest statistics from the International Society of Aesthetic Plastic Surgery (ISAPS). The US also retained
- BOTOX Cosmetic, IFundWomen Launch Crowdfunding Campaignshttps://modernaesthetics.com/news/botox-cosmetic-and-ifundwomen-launch-crowdfunding-campaigns/2473493/Allergan Aesthetics announced the next chapter of the BOTOX Cosmetic and IFundWomen grant program with the launch of crowdfunding campaigns for the women entrepreneurs. The brand
- Cutera Introduces Secret DUOhttps://modernaesthetics.com/news/cutera-introduces-secret-duo/2473490/Cutera, Inc. is launching Secret DUO, a skin resurfacing and revitalization platform that utilizes dual non-ablative fractional technologies. Each modality can be used individually or in combination to target a wide range of aesthetic indications. Secret DUO is equipped
- SkinCeuticals Launches National Treatment Tourhttps://modernaesthetics.com/news/skinceuticals-launches-national-treatment-tour/2473489/SkinCeuticals is kicking off its national treatment tour. The SkinCeuticals Treatment Tour aims to spread awareness on the importance of pairing treatments and skincare for optimal results and offers an op
- Why I Sold: Dr. Brian Biesman Joins MedSpa Partnershttps://modernaesthetics.com/news/why-i-sold-dr-brian-biesman-joins-medspa-partners/2473487/Nashville-based oculofacial plastic surgeon Dr. Brian Biesman is joining MedSpa Partners (MSP) Inc. "I'm excited for us to join such a talented and accomplished group of practices and practitioners. We have always prided ourselves on our commitment to rigorously